Experienced in Prostate Cancer

Hideki Maeda

Kiyose, JP 
Experienced in Prostate Cancer
Kiyose, JP 
OverviewLocationsClinical Research

Overview

Hideki Maeda practices in Kiyose, Japan. Mr. Maeda is rated as an Experienced expert by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Breast Cancer, Agranulocytosis, Ventricular Fibrillation, Prostate Cancer, and Thyroidectomy.

His clinical research consists of co-authoring 71 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 6 articles in the study of Prostate Cancer.

Gender
Male

Locations

Kiyose, 2045255, Japan
Other Locations
Sapporo, Japan
Tokyo, Japan
Meiji, Japan
Nagoya, Japan
Japan
Nishinihon Station, Kasaoka, 7140054, Japan
Kyoto, Japan
Chuo, 1038411, Japan
Minato, Japan
Hamamatsu, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized, Double-blind, Phase 3 Study of Tucatinib or Placebo in Combination With Trastuzumab and Pertuzumab as Maintenance Therapy for Metastatic HER2+ Breast Cancer (HER2CLIMB-05)
A Randomized, Double-blind, Phase 3 Study of Tucatinib or Placebo in Combination With Trastuzumab and Pertuzumab as Maintenance Therapy for Metastatic HER2+ Breast Cancer (HER2CLIMB-05)
Enrollment Status: Active_not_recruiting
Publish Date: October 14, 2025
Intervention Type: Drug
Study Drugs: Tucatinib, Trastuzumab, Pertuzumab
Study Phase: Phase 3

71 Total Publications

Electronic Patient-Reported Outcomes With Vital Sign Monitoring During Trastuzumab Deruxtecan Therapy: The PRO-DUCE Randomized Clinical Trial.
Electronic Patient-Reported Outcomes With Vital Sign Monitoring During Trastuzumab Deruxtecan Therapy: The PRO-DUCE Randomized Clinical Trial.
Journal: JAMA network open
Published: August 15, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Maeda's expertise for a condition
ConditionClose
        View All 10 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile